Antenatal steroids and intraventricular hemorrhage after premature rupture of membranes at 24-28 weeks' gestation

American Journal of Perinatology

Volumn 14, Issue 3, 1997, Pages 171-176

  Chen, Bruce ^a,b   Basil, Jack B ^a   Schefft, Georgia L ^a   Cole, F Sessions ^a   Sadovsky, Yoel ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

Corticosteroids; intraventricular hemorrhage; premature rupture of membranes

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INCIDENCE; INFECTIOUS COMPLICATION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0031000727     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994121     Document Type: Article

References (31)

1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants. Pediatrics 1972; 50:515-34
2. National Institutes of Health Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994. Am J Obstet Gynecol 1995;173:246-52
3. American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice. Antenatal corticosteroids therapy for fetal maturation. ACOG Committee Opinion 1994;147
4. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254-62
5. Garite JT, Rumney PJ, Briggs GG, et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992;166:646-51
6. Leviton LC, Baker S, Hassol A, Goldenberg RL. An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids. Am J Obstet Gynecol 1995; 173:312-16
7. Papile LA, Burnstein J, Burnstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 grams. J Pediatr 1978;92:529-34
8. Meidell R, Marinelli P, Bettett G. Perinatal factors associated with early-onset intracranial hemorrhage in premature infants: A prospective study. Am J Dis Child 1985; 139:160-63
9. Ment LR, Oh W, Philip AGS, et al. Risk factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr 1992;121:776-83
10. O'Shea M, Savitz DA, Hage ML, Feinstein KA. Prenatal events and the risk of subependymal/intraventricular haemorrhage in very low birthweight neonates. Paediatr Perinat Epidemiol 1992;6:356-62
11. Bada HS, Korones SB, Anderson GD, Magill HL, Wong SP. Obstetric factors and relative risk of neonatal germinal layer/intraventricular hemorrhage. Am J Obstet Gynecol 1984;148:798-804
12. Hack M, Horbar JD, Malloy MH, Tyson JE, Wright E, Wright L. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics 1991;87:587-97
13. Shankaran S, Bauer CR, Bain RB, Wright LL, Zachary J. Relationship between antenatal steroid administration and grades III and IV intracranial hemorrhage in low birth weight infants. Am J Obstet Gynecol 1995;173:305-12
14. Morales WJ, Koerten J. Obstetric management and intraventricular hemorrhage in very-low-birth-weight infants. Obstet Gynecol 1986;68:35-40
15. Yoon JJ, Harper RG. Observations of the relationship between duration of rupture of membranes and the development of idiopathic respiratory distress syndrome. Pediatrics 1973;52:161-68
16. Bauer CR, Stern L, Colle E. Prolonged rupture of membranes associated with a decreased incidence of respiratory distress syndrome. Pediatrics 1974;53:7-12
17. Crowley P. Corticosteroids after preterm premature rupture of membranes. Obstet Gynecol Clin North Am 1992;19: 317-26
18. Ohlsson A. Treatments of preterm premature rupture of the membranes: A meta-analysis. Am J Obstet Gynecol 1990;162:1353-55
19. Maher J, Goldenberg RL. Outcomes of very-low-birth-weight infants after maternal corticosteroid therapy before 28 weeks' gestation [letter]. Am J Obstet Gynecol 1993;169:1363-64
20. Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr 1995;126:272-79
21. Silver RK, Vyskocil C, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation. Obstet Gynecol 1996;87:683-91
22. Garfinkel E, Verma UL. Periventricular/intraventricular hemorrhage and periventricular leukomalacia: Obstetrical antecedents and long-term sequelae. In Tejani N (ed): Obstetrical Events and Developmental Sequelae, 2nd ed. Boca Raton: CRC Press, 1994, pp 187-202
23. Peri KG, Hardy P, Li DY, Varma DR, Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem 1995;270: 24615-20
24. Ment LR, Stewart WB, Duncan CC. Beagle puppy model of intraventricular hemorrhage: Ethamsylate studies. Prostaglandins 1984;27:245-56
25. Ment LR, Oh W, Ehrenkranz RA, Philip AGS, Duncan CC, Makuch RW. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795-800
26. Clark CE, Clyman RI, Roth RS, Sniderman SH, Lane B, Ballard RA. Risk factor analysis of intraventricular hemorrhage in low-birth-weight infants. J Pediatr 1981;99:625-28
27. Gibbs RS, Blanco JD. Premature rupture of membranes. Obstet Gynecol 1982;60:671-79
28. Schmidt PL, Sims ME, Strassner HT, Paul RH, Mueller E, McCart D. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 1984;148: 178-86
29. Kuban KCK, Leviton A, Pagano M, et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992; 7:70-76
30. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-69
31. Lemons J, Stevenson D, Verter J, et al. In utero magnesium exposure: Risk of death and intraventricular hemorrhage (IVH) in very low birth weight (VLBW) infants (abstract). Pediatr Res 1996;39:225A